These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 35509260)

  • 1. Characterising body composition and bone health in transgender individuals receiving gender-affirming hormone therapy.
    Ford K; Huggins E; Sheean P
    J Hum Nutr Diet; 2022 Dec; 35(6):1105-1114. PubMed ID: 35509260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of gender-affirming hormone therapy on insulin resistance and body composition in transgender individuals: A systematic review.
    Spanos C; Bretherton I; Zajac JD; Cheung AS
    World J Diabetes; 2020 Mar; 11(3):66-77. PubMed ID: 32180895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone health and body composition in transgender adults before gender-affirming hormonal therapy: data from the COMET study.
    Ceolin C; Scala A; Dall'Agnol M; Ziliotto C; Delbarba A; Facondo P; Citron A; Vescovi B; Pasqualini S; Giannini S; Camozzi V; Cappelli C; Bertocco A; De Rui M; Coin A; Sergi G; Ferlin A; Garolla A;
    J Endocrinol Invest; 2024 Feb; 47(2):401-410. PubMed ID: 37450195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men.
    Pirtea P; Ayoubi JM; Desmedt S; T'Sjoen G
    Fertil Steril; 2021 Oct; 116(4):936-942. PubMed ID: 34481638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender-affirming hormone therapy for transgender and gender-diverse adults in Australia.
    Nolan BJ; Cheung AS
    Intern Med J; 2024 Sep; 54(9):1450-1457. PubMed ID: 39056542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender-Affirming Hormone Therapy and Bone Health: Do Different Regimens Influence Outcomes in Transgender Adults? A Narrative Review and Call for Future Studies.
    Cirrincione LR; Narla RR
    J Appl Lab Med; 2021 Jan; 6(1):219-235. PubMed ID: 33432334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time Course of Body Composition Changes in Transgender Adolescents During Puberty Suppression and Sex Hormone Treatment.
    Boogers LS; Reijtenbagh SJP; Wiepjes CM; van Trotsenburg ASP; den Heijer M; Hannema SE
    J Clin Endocrinol Metab; 2024 Jul; 109(8):e1593-e1601. PubMed ID: 38128064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of gender affirming hormone therapy on body mass index in transgender individuals: A longitudinal cohort study.
    Suppakitjanusant P; Ji Y; Stevenson MO; Chantrapanichkul P; Sineath RC; Goodman M; Alvarez JA; Tangpricha V
    J Clin Transl Endocrinol; 2020 Sep; 21():100230. PubMed ID: 32685379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals-A systematic review.
    McFarlane T; Zajac JD; Cheung AS
    Clin Endocrinol (Oxf); 2018 Dec; 89(6):700-711. PubMed ID: 30107028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body Composition and Markers of Cardiometabolic Health in Transgender Youth Compared With Cisgender Youth.
    Nokoff NJ; Scarbro SL; Moreau KL; Zeitler P; Nadeau KJ; Juarez-Colunga E; Kelsey MM
    J Clin Endocrinol Metab; 2020 Mar; 105(3):e704-14. PubMed ID: 31544944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
    Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
    J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks.
    Sudhakar D; Huang Z; Zietkowski M; Powell N; Fisher AR
    Neurourol Urodyn; 2023 Jun; 42(5):903-920. PubMed ID: 36403287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical and Sociodemographic Features Associated With Quality of Life Among Transgender Women and Men Using Gender-Affirming Hormone Therapy.
    Silva ED; Fighera TM; Allgayer RM; Lobato MIR; Spritzer PM
    Front Psychiatry; 2021; 12():621075. PubMed ID: 34381383
    [No Abstract]   [Full Text] [Related]  

  • 14. SERUM HORMONE CONCENTRATIONS IN TRANSGENDER INDIVIDUALS RECEIVING GENDER-AFFIRMING HORMONE THERAPY: A LONGITUDINAL RETROSPECTIVE COHORT STUDY.
    Chantrapanichkul P; Stevenson MO; Suppakitjanusant P; Goodman M; Tangpricha V
    Endocr Pract; 2021 Jan; 27(1):27-33. PubMed ID: 33471729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender affirming hormonal treatment in Danish transgender persons: A nationwide register-based study.
    Glintborg D; Rubin KH; Kristensen SB; Lidegaard Ø; T'Sjoen G; Hilden M; Andersen MS
    Andrology; 2022 Jul; 10(5):885-893. PubMed ID: 35366390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Gender-Affirming Hormone Therapy on the Risk of Subclinical Atherosclerosis in the Transgender Population: A Systematic Review.
    Moreira Allgayer RMC; Borba GDS; Moraes RS; Ramos RB; Spritzer PM
    Endocr Pract; 2023 Jun; 29(6):498-507. PubMed ID: 36603652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender-affirming pharmacotherapy and additional health considerations: A contemporary review.
    Mercer J; Bandy S; Tang H; Wenger B; Ryan L; Lee G; Lipscomb J
    J Am Pharm Assoc (2003); 2023; 63(6):1669-1676.e1. PubMed ID: 37619851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent vaginal bleeding during gender-affirming hormone therapy in transgender men.
    da Silva ED; Spritzer PM; Fighera TM
    J Endocrinol Invest; 2024 Aug; 47(8):2053-2060. PubMed ID: 38300501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Gender-Affirming Hormone Therapy on Physical Performance.
    Cheung AS; Zwickl S; Miller K; Nolan BJ; Wong AFQ; Jones P; Eynon N
    J Clin Endocrinol Metab; 2024 Jan; 109(2):e455-e465. PubMed ID: 37437247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding upon the relationship between gender-affirming hormone therapy, neural connectivity, mental health, and body image dissatisfaction.
    Grannis C; Mattson WI; Leibowitz SF; Nahata L; Chen D; Strang JF; Thobe H; Indyk JA; Nelson EE
    Psychoneuroendocrinology; 2023 Oct; 156():106319. PubMed ID: 37331310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.